Crossmark

Quantitative ex vivo assessment of target temperature and ablation duration for protocol optimization of microwave ablation procedures with mr thermometry

Crossref DOI link: https://doi.org/10.1038/s41598-026-41656-3

Published Online: 2026-03-03

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Nardone, Luigi

Tan, Alexander Sheng Ming

Bour, Pierre

Fabritius, Matthias Philipp

Öcal, Elif

Schmidt, Vanessa Franziska

Wu, Mingming

Bauer, Laura Maria

Ozenne, Valéry

Ricke, Jens

Seidensticker, Max

Dietrich, Olaf
Funding

Funding for this research was provided by:

Klinikum der Universität München
License Information

Text and Data Mining valid from 2026-03-03

Version of Record valid from 2026-03-04
More Information

Article History

Received: 24 November 2025

Accepted: 23 February 2026

First Online: 3 March 2026

Declarations

:

: PB is an employee of Certis Therapeutics. VO is co-founder and shareholders of Certis Therapeutics. The LMU University Hospital has a Master Research Agreement with Siemens Healthineers.

Document is current

Any future updates will be listed below